Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzhou Tianma Pharma Group is a prominent Chinese life sciences company specializing in the development and manufacture of active pharmaceutical ingredients (APIs) and fine chemicals. Established in 1993 and based in Suzhou, the company has built a global reputation as a leading supplier of protected amino acids and peptide building blocks. Their extensive product portfolio includes generic APIs for treating viral infections, cardiovascular diseases, and oncological conditions. Suzhou Tianma operates state-of-the-art, GMP-certified manufacturing facilities and provides comprehensive CDMO services, including custom synthesis and process optimization. The company serves a diverse clientele ranging from global pharmaceutical giants to emerging biotech firms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suzhou Tianma Specialty Chemicals.